Keep up to date
- Univercells news | 16.05.2018
Univercells hits the ground running with new Equipment Design Center
Due to burgeoning development at its Gosselies facility creating the need for more space, Univercells has expanded its activities to ...
- In the press | 01.02.2018
David Shofi appointed Chief Legal Officer at Univercells
Announcing David Shofi, our new Chief Legal Officer and first US-based partner! His 20+ years in IP & general corporate ...
- Press release | 22.01.2018
Univercells to receive €2.4M from Walloon Region for its “Universimilar” program
New endowment to open avenues for the development of Univercells’ innovative antibody manufacturing platform – its ultimate goal being to ...
- Univercells news | 21.12.2017
Season’s greetings from Univercells
The best is yet to come...
- Press release | 15.12.2017
Univercells secures €3M Series A2 funding
This capital injection will help accelerate the development and commercialization of the company’s technology platforms and innovative solutions
- Univercells news | 08.11.2017
Univercells joins the Belgian State Visit to India
Hugues Bultot, CEO of Univercells, joins the Belgian business delegation to further develop collaborative efforts and...
- Univercells news | 28.09.2017
Univercells Excellence Award
Congratulations to Aline Jordens, valedictorian and laureate of the excellence award delivered by David Louvet. The proclamation ceremony of the ...
- Press release | 12.09.2017
Doug Neugold appointed Chairman of the Board
Mr. Neugold, a seasoned executive with extensive industry experience in single-use bioprocess solutions, has been appointed as chairman of our ...
Download Univercells company profile, logo, and picturesPress kit
Belgium Press Inquiries
Univercells - Marketing & Communication firstname.lastname@example.org
International Press Inquiries
Andrew Lloyd & Associates - Juliette Dos Santosjuliette@ala.com
"Disruptive micro-facilities for affordable vaccine manufacturing"
BIO Europe Spring
"Innovative approaches to funding vaccines for emerging pandemics"